Can GLP-1 Weight-Loss Drugs Help With Sleep Apnea? Experts Explain
Summary
Researchers are studying whether weight-loss drugs called GLP-1 receptor agonists (like Ozempic and Wegovy) can help people with obstructive sleep apnea. This common sleep disorder, linked to obesity, causes repeated breathing interruptions during sleep and can increase risk of heart disease and stroke.Key Facts
- Obstructive sleep apnea affects nearly 1 billion people worldwide and causes breathing problems during sleep due to blocked airways.
- Around 60-70% of sleep apnea patients are obese, defined as having a body mass index (BMI) of 30 or higher.
- Obesity narrows the airway and reduces lung capacity, making sleep apnea worse.
- A major study (the SCALE Sleep Apnea trial) is the first to test GLP-1 drugs specifically on sleep apnea patients.
- Weight gain increases the severity of sleep apnea, while losing weight improves it.
- GLP-1 receptor agonists have shown potential to help some patients with this condition by reducing body weight.
- Not all people with sleep apnea are obese, so weight-loss drugs may not help everyone with the disorder.
- The airway affected in sleep apnea is a soft tube kept open by muscles, and obesity causes fat to press on these muscles, narrowing the airway.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
